Condition: Esophageal Cancer · Sponsor: Shanghai Chest Hospital
The ad-ESD trial is phase III randomized trial to compare adjuvant esophagectomy and chemoradiation for patients with clinical stage N0 and pathological stage T1b squamous cell carcinoma (after endoscopic submucosal dissection).
This description comes directly from the study's public registry record.
Zhigang Li, MD · 18960619260 · dr_lizhigang@163.com
Xiaobin Zhang, MD · 18516302162 · zxb5212@163.com
Always discuss trial participation with your own doctor first.
| The First Affiliated Hospital of Nanchang University | Nanchang, Jiangxi, China | Active Not Recruiting |
| Changhai Hospital, The Second Military Medical University | Shanghai, China | Active Not Recruiting |
| Ruijin Hospital, Shanghai Jiao Tong University, School of Medicine | Shanghai, China | Active Not Recruiting |
| Shanghai Chest Hospital, Shanghai Jiao Tong University | Shanghai, China | Recruiting |
| Zhongshan Hospital, Fudan University | Shanghai, China | Active Not Recruiting |
| Tianjin Medical University Cancer Institute and Hospital | Tianjin, China | Active Not Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04135664